Bird & Bird advises the founders of Nimbus Health GmbH on sale to Dr. Reddy's Laboratoires

Contacts

kai kerger Module
Dr. Kai Kerger

Partner
Germany

I am an experienced transaction lawyer and a partner in our corporate/M&A team in Frankfurt am Main and offer years of expertise advising clients in national and cross-border M&A, private equity and venture capital transactions, investments of all kinds, in complex restructurings and reorganisations and joint ventures, in particular in projects with a special technology focus as well as in general corporate and commercial law matters.

Bird & Bird LLP advised the founders of Nimbus Health GmbH on the sale of all shares to Dr. Reddy's Laboratories ("Dr. Reddy's"). The parties have agreed not to disclose the purchase price.

Nimbus Health is one of the leading pharmaceutical companies for cannabinoid-based medicinal products in Germany (medicinal cannabis) and is fully licensed to import, register and trade in medicinal products and narcotics. As a pharmaceutical wholesaler and manufacturer with its own warehousing facilities and independent sales force, Nimbus Health distributes medicinal cannabis products to pharmacists.

Dr. Reddy's is an international pharmaceutical and generics company based in India. Its key therapeutic areas include pain management, oncology and dermatology. With the acquisition, Dr. Reddy's will build on Nimbus Health's strengths and introduce cannabis-based medicines as a promising treatment option for patients. The company will operate under the Nimbus Health brand and as a wholly owned subsidiary of Dr. Reddy's.

The closing of the transaction is subject to customary closing conditions.

The following Bird & Bird lawyers were involved: Partner Dr. Kai Kerger (lead), associates Johanna Schindler and Tamara Böhmert (all Corporate/M&A, Frankfurt), partner Dr. Niels Lutzhöft, LL.M. and associate Dr. Simon Hembt (both Commercial/Regulatory, Frankfurt), partner Dr. Barbara Geck and associates Franziska Fiedler and Carina Seum (all Employment, Frankfurt), partner Dr. Michael Jünemann and associate Julia Fröhder (both Finance & Financial Regulation, Frankfurt).

News & Deals

More News & Deals

Deal

Bird & Bird advises Edita Group on Divestment of Edita Prima

Nov 04 2024

Read More

Deal

Bird & Bird advised Sydev on its partnership with Turenne Emergence

Oct 30 2024

Read More

Deal

Bird & Bird advise Emerge Education on its participation in Mendo's fundraising round

Oct 30 2024

Read More

Deal

Bird & Bird advises Mothercare Global Brand Limited on sale of shares

Oct 30 2024

Read More

News

Bird & Bird advise Novo Nordisk Foundation as Denmark launches its first AI supercomputer

Oct 24 2024

Read More

Deal

The Bird & Bird M&A team in Prague advised Vendep Capital on its strategic investment in Eyeball s.r.o

Oct 24 2024

Read More